Counteracting Age-related Loss of Skeletal Muscle Mass (CALM) (CALM)
Counteracting Age-related Loss of Skeletal Muscle Mass
Sponsor: Arla Foods
Listed as NCT02115698, this NA trial focuses on Muscle Loss and Sarcopenia and remains completed. Sponsored by Arla Foods, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — May 2023 [monthly]
Completed NA
-
Dec 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
Jan 2019 — Dec 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Oct 2017 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arla Foods
- Bispebjerg Hospital
- University of Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .